About
Recor Medical is a medical technology company based in Palo Alto, California, dedicated to improving the management of hypertension, a major cardiovascular risk factor. Founded in 2009, the company focuses on developing innovative therapies using ultrasound technology. Its flagship product, the Paradise™ Ultrasound Renal Denervation (uRDN) System, is a minimally invasive device that lowers blood pressure by targeting the sympathetic nerves around the renal arteries. The Paradise system utilizes 360-degree ultrasound energy delivered through a balloon catheter with a HydroCooling™ system to protect the renal artery wall during the procedure. Clinical trials have shown significant reductions in office systolic blood pressure, with sustained results up to three years post-procedure. The device has received FDA approval for commercial use in the United States and holds CE marking for European markets. As a subsidiary of Otsuka Medical Devices Co., Ltd., Recor Medical is committed to providing new therapeutic options for patients with hypertension, particularly those who do not respond adequately to traditional treatments.
Technologies
Keywords
Company Information
-
Employees 320
-
Founded 2009
-
Annual Revenue $6000000
-
Total Funding $37000000
Location
1049 Elwell Ct, Palo Alto, California, United States, 94303